Related Experiment Videos
Future trends in aminoglycoside therapy
The American Journal of Medicine
|June 30, 1986
Summary
Aminoglycosides remain crucial for treating serious gram-negative infections, especially with emerging antibiotic resistance. Their continued use in hospital-acquired infections and specific conditions is vital.
Area of Science:
- Pharmacology
- Infectious Diseases
- Microbiology
Background:
- Aminoglycosides have been mainstays in treating bacterial infections for 30 years.
- Concerns about aminoglycoside limitations and new antibiotic development have questioned their future role.
- Emerging resistance to newer antibiotics necessitates a re-evaluation of established agents.
Purpose of the Study:
- To assess the continuing role of aminoglycosides in treating nosocomial infections.
- To identify factors influencing the future use of aminoglycosides in clinical practice.
- To highlight the importance of aminoglycosides in specific patient populations and infection types.
Main Methods:
- Literature review and analysis of current trends in antibiotic resistance and usage.
- Evaluation of clinical scenarios where aminoglycosides are essential.
- Consideration of economic and administrative factors impacting antibiotic selection.
Main Results:
- Resistance to new antibiotics is evident, ensuring a continuing role for aminoglycosides.
- Aminoglycosides will remain important for empiric and synergistic therapy in specific infections.
- Key applications include hospital-acquired infections in neutropenic patients, enterococcal endocarditis, and Pseudomonas aeruginosa infections.
Conclusions:
- Aminoglycosides will continue to be essential in treating complex nosocomial infections.
- Factors like cost, new drug discovery, and combination therapy will shape their future use.
- Despite challenges, aminoglycosides offer a valuable therapeutic option against resistant gram-negative pathogens.